Singular Genomics Systems Inc reports results for the quarter ended in June - Earnings Summary

Singular Genomics Systems

09/08/2022 23:01

* Singular Genomics Systems Inc  OMIC.OQ  reported a
quarterly
adjusted loss of 34 cents​​ per share for the quarter ended in
June. The mean expectation of five analysts for the quarter was
for a loss of 38 cents per share.
    * Reported revenue was zero​; analysts expected $50.00
thousand. 
    * Singular Genomics Systems Inc's reported EPS for the
quarter was
a loss of 34 cents​.
    * The mean earnings estimate of analysts had risen by
about 0.9%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Singular Genomics Systems Inc shares had risen by 20.9%
this
quarter and lost 60.0% so far this year.
    * The company reported a quarterly loss of $23.98 million.
    * Wall Street's median 12-month price target for Singular
Genomics
Systems Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 9
at 10:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.38          -0.34          Beat
 Mar. 31 2022      -0.33          -0.31          Beat
 Dec. 31 2021      -0.31          -0.27          Beat
 Sep. 30 2021      -0.24          -0.25          Missed